Clinical Trial Update: Clofarabine Salvage Therapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) [Phase 2]

View source ↗

Summary

This clinical trial update notes the completion of a Phase 2 study evaluating clofarabine as salvage therapy for relapsed or refractory acute myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Clolar (Clofarabine)

Snippet

Sponsor: Technische Universität Dresden | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: COMPLETED